Agilon Health (NYSE:AGL) Shares Up 6.8% – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s stock price traded up 6.8% during mid-day trading on Wednesday . The company traded as high as $115.56 and last traded at $114.76. 101,823 shares were traded during trading, a decline of 71% from the average daily volume of 350,864 shares. The stock had previously closed at $107.47.

Analysts Set New Price Targets

Several analysts recently issued reports on AGL shares. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective for the company. in a report on Monday, May 4th. TD Cowen reaffirmed a “hold” rating and issued a $55.00 target price (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. Benchmark reiterated a “buy” rating and set a $95.00 price target (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Finally, Jefferies Financial Group upgraded Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $27.50 to $48.00 in a report on Thursday, May 7th. Five analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Agilon Health has a consensus rating of “Hold” and a consensus target price of $58.73.

Agilon Health Stock Performance

The firm has a fifty day simple moving average of $87.34 and a 200 day simple moving average of $42.03. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market cap of $1.92 billion, a price-to-earnings ratio of -5.31 and a beta of 2.98.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. On average, sell-side analysts expect that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. North Peak Capital Management LLC boosted its position in shares of Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after acquiring an additional 3,715,460 shares during the period. Goldman Sachs Group Inc. grew its position in Agilon Health by 196.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after purchasing an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Agilon Health by 30.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock valued at $5,523,000 after buying an additional 1,893,434 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Agilon Health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock valued at $4,944,000 after buying an additional 35,054 shares during the period.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.